Cargando…
A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization
Gefitinib is an anticancer agent which acts by inhibiting epidermal growth factor receptor tyrosine kinase receptors. The aim of the present study was to prepare gefitinib nanosuspension. Gefitinib was encapsulated in Eudragit(®) RL100 and then dispersed in stabilizer solution, polyvinyl alcohol, an...
Autores principales: | Kola Srinivas, Navya Sree, Verma, Ruchi, Pai Kulyadi, Girish, Kumar, Lalit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179202/ https://www.ncbi.nlm.nih.gov/pubmed/28031710 http://dx.doi.org/10.2147/IJN.S122729 |
Ejemplares similares
-
Polymeric Nanocarriers for the Delivery of Antimalarials
por: Mhlwatika, Zandile, et al.
Publicado: (2018) -
Formulation optimization, in vitro and in vivo evaluation of niosomal nanocarriers for enhanced topical delivery of cetirizine
por: Aldawsari, Mohammed F., et al.
Publicado: (2023) -
Delivery of gefitinib with an immunostimulatory nanocarrier improves therapeutic efficacy in lung cancer
por: Diao, Dingwei, et al.
Publicado: (2021) -
In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis
por: Tagalakis, Aristides D., et al.
Publicado: (2018) -
Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy
por: Avramović, Nataša, et al.
Publicado: (2020)